These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29080707)

  • 21. Highly efficient nuclear delivery of anti-cancer drugs using a bio-functionalized reduced graphene oxide.
    Zheng XT; Ma XQ; Li CM
    J Colloid Interface Sci; 2016 Apr; 467():35-42. PubMed ID: 26773607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of hollow core/shell Fe
    Wang J; Fang J; Fang P; Li X; Wu S; Zhang W; Li S
    J Biomater Sci Polym Ed; 2017 Mar; 28(4):337-349. PubMed ID: 27931160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-assembled graphene-dextran nanohybrid for killing drug-resistant cancer cells.
    Jin R; Ji X; Yang Y; Wang H; Cao A
    ACS Appl Mater Interfaces; 2013 Aug; 5(15):7181-9. PubMed ID: 23875578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dextran-based doxorubicin nanocarriers with improved tumor penetration.
    Sagnella SM; Duong H; MacMillan A; Boyer C; Whan R; McCarroll JA; Davis TP; Kavallaris M
    Biomacromolecules; 2014 Jan; 15(1):262-75. PubMed ID: 24313925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system.
    Javanbakht S; Pooresmaeil M; Namazi H
    Carbohydr Polym; 2019 Mar; 208():294-301. PubMed ID: 30658803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
    Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
    Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SERS-fluorescence monitored drug release of a redox-responsive nanocarrier based on graphene oxide in tumor cells.
    Chen H; Wang Z; Zong S; Wu L; Chen P; Zhu D; Wang C; Xu S; Cui Y
    ACS Appl Mater Interfaces; 2014 Oct; 6(20):17526-33. PubMed ID: 25272041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells.
    Tarvirdipour S; Vasheghani-Farahani E; Soleimani M; Bardania H
    Int J Pharm; 2016 Mar; 501(1-2):331-41. PubMed ID: 26875475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
    Zhang B; Yang X; Wang Y; Zhai G
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line.
    Bikhof Torbati M; Ebrahimian M; Yousefi M; Shaabanzadeh M
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):568-573. PubMed ID: 27027552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery.
    Du YZ; Weng Q; Yuan H; Hu FQ
    ACS Nano; 2010 Nov; 4(11):6894-902. PubMed ID: 20939508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier.
    Xu Z; Zhu S; Wang M; Li Y; Shi P; Huang X
    ACS Appl Mater Interfaces; 2015 Jan; 7(2):1355-63. PubMed ID: 25546399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems.
    Pan Q; Lv Y; Williams GR; Tao L; Yang H; Li H; Zhu L
    Carbohydr Polym; 2016 Oct; 151():812-820. PubMed ID: 27474628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations.
    Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z
    ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
    Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
    J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Redox-responsive biodegradable PEGylated nanographene oxide for efficiently chemo-photothermal therapy: a comparative study with non-biodegradable PEGylated nanographene oxide.
    Xiong H; Guo Z; Zhang W; Zhong H; Liu S; Ji Y
    J Photochem Photobiol B; 2014 Sep; 138():191-201. PubMed ID: 24976623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
    Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs.
    Shim G; Kim JY; Han J; Chung SW; Lee S; Byun Y; Oh YK
    J Control Release; 2014 Sep; 189():80-9. PubMed ID: 24973719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterization of doxorubicin modified ZnO/PEG nanomaterials and its photodynamic action.
    Hariharan R; Senthilkumar S; Suganthi A; Rajarajan M
    J Photochem Photobiol B; 2012 Nov; 116():56-65. PubMed ID: 22982207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Boronate-dextran: an acid-responsive biodegradable polymer for drug delivery.
    Li L; Bai Z; Levkin PA
    Biomaterials; 2013 Nov; 34(33):8504-10. PubMed ID: 23932249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.